Our leadership team has the experience and track record required to make your project a success.
MEET THE EXPERTS
Renaissance recognizes that our clients’ development programs and commercial products rely on quality and service to meet the expectations of their patients.
We work passionately as a contract manufacturer of pharmaceutical products that you can trust. Renaissance leadership consists of a highly experienced team of pharma services veterans with an average of 20 years of experience in the pharmaceutical industry. Our team has an impeccable track record of executing our clients’ projects and growing Renaissance into a leading CDMO.
At our state-of-the-art facility in Lakewood, NJ, we can develop and manufacture a broad range of nasal and sterile injectable products. From early-stage development through final production, Renaissance has the expertise and resources needed to support any size program. We look forward to the opportunity to support your projects.
President & CEO
Serge Maltais serves as President and CEO of Renaissance. With over 30 years of experience in managing operations and leading teams in the pharmaceutical space, he is adept at developing and implementing innovative solutions and achieving results. Previously, Serge served as President and CEO of Héma-Québec, a governmental non-profit organization that manages the supply of blood, human tissues, cord blood, and maternal milk throughout Quebec, Canada. Prior to that, Serge served as VP Supply Chain & Commercial Operations for Sandoz in Canada, and held positions of increasing responsibility within Manufacturing and Operations at Baxter. Serge holds a Bachelor of Industrial Engineering from École Polytechnique in Montréal, as well as a Diploma in Business Administration from Université de Sherbrooke, Sherbrooke.
Robert Harrer serves as the CFO of Renaissance. He has over 25 years of experience in financial management, with a strong operational focus in the specialty chemicals and pharmaceutical industry. Previously, he served as CFO at Avantor and Innophos, and held various financial leadership positions at Rohm and Haas. He is a member of the board of directors of KMG Chemicals.
Robert received his Master of Business Administration and Mathematics from Albert Einstein University in Ulm, Germany.
VP – CHRO
Brenda Vesey serves as the VP – CHRO for Renaissance. She has over 25 years of experience in HR across multiple industries. She has served on a number of Executive Leadership teams and has held a variety of HR leadership roles within the pharmaceutical industry including roles at Teva Pharmaceuticals, Allergan, Actavis, and Alpharma. Prior to that she worked for Toys “R” Us and Chase Manhattan Corporation. While at Chase she worked in both Financial Operations and Human Resources.
Brenda is a graduate of Siena College in Loudonville, NY, where she earned a B.S. degree in Economics.
VP of Strategic and Business Development
Julie Simon serves as the VP of Strategic and Business Development for Renaissance. She has over 15 years of management experience in the pharmaceutical industry, with a history of success in identifying & executing unique business opportunities, organizational transformation, and value creation. Julie previously held leadership positions with Ben Venue/Bedford Laboratories, Akorn, APP/Abraxis, Bioniche Pharma and Mylan. Her experience spans commercial, operational and technical verticals, with focus on Business Development, M&A, Commercial Operations, R&D, Strategic Sourcing and Quality.
VP, Product Development and Laboratory Services
Kimberly Ernst serves as the VP of Product Development and Regulatory Affairs. Kim is a seasoned leader with 15 years of experience in the pharmaceutical industry. She has deep experience in preparing regulatory submissions, strategizing effective regulatory pathways, and developing innovative approaches. Before joining Renaissance, Kim worked at Impax Laboratories (via CorePharma acquisition) as the Senior Director, Regulatory Affairs. Prior to Impax she worked in roles of increasing responsibility at Dr. Reddy’s Laboratories, B. Braun Medical Inc, and Teva Pharmaceuticals.
Kim holds a B.S. in Chemistry from Cedar Crest College and an M.S. in Chemistry from Lehigh University.
Vice President of Quality
Dan Brennan serves as the Vice President of Quality at Renaissance. Dan has over 28 years of pharmaceutical experience primarily with sterile injectable products. During these 28 years Dan has held positions of increasing responsibility in Laboratories, Quality Assurance and Manufacturing with Merck and Pfizer.
Dan holds a BS degree from Stockton State College, Pomona, NJ an MS from West Chester University, West Chester, PA and an MSc in Pharmaceutical Quality from the University of Strathclyde, Glasgow, Scotland.
VP of Sales & Marketing
Eric Kaneps serves as the VP of Sales & Marketing. Eric has over 20 years of experience in Sales, Business Development, and Account Management in the pharmaceutical industry.
Prior to joining Renaissance, Eric led Business Development for Pharma-Tech Industries, a contract manufacturing organization that specializes in prescription and over-the-counter ingestibles and topical products. While there, Eric was responsible for new market expansion through the addition of development services offerings and capability expansion to support drug-device combination products. Prior to Pharma-Tech Industries, Eric worked at DPT Laboratories, Alcan Packaging, and Drug Plastics & Glass Co.
Eric holds a B.S. B.A. in International Business & Economics from The Ohio State University.
Vice President, Commercial Services & Supply Chain
Al Atkinson serves as Senior Director of Commercial Services, leading the team responsible for commercial account management. He has over 20 years of leadership experience in Pharmaceutical Manufacturing, Quality Systems, Program Management and Commercial Operations.
Prior to joining Renaissance, Al was Sr. Director of Development Services and Commercial Operations for DPT Laboratories, a Mylan company. In this role, Al had responsibility for the CDMO product development and commercial operations teams as well as oversight of internal tech transfers and repatriation programs for the proprietary business. Prior to this role, Al held positions of increasing responsibility in Manufacturing, Project Management, Quality Systems, Development and Commercial Services.